ASH 2017: Dr. Furman Discusses Acalabrutinib for Treating Chronic Lymphocytic Leukemia (CLL) At the 2017 ASH Annual Meeting held in Atlanta, GA, I spoke with Dr. Richard Furman from Weill Cornell Medical... March 20, 2018NewsBy Todd Dennison
Heading to Seattle: My Best Chance and Place to Knock Back my Nasty Chronic Lymphocytic Leukemia (CLL) I have taught others when I speak on self-advocacy that we must make life changing decision with conflicting advice and... February 25, 20181 CommentCAR-T Blog, NewsBy Brian Koffman
Verastem Submits NDA to FDA for Duvelisib for Relapsed/Refractory CLL February 8, 2018 - A new drug application (NDA) has been submitted to the FDA for duvelisib for a full... February 8, 2018Business, Finances, Insurance & RegulatoryBy Todd Dennison
Celgene Acquires JUNO On Jan. 22, 2018 Celgene announced they had acquired JUNO. Celgene is a large well established pharmaceutical company with a strong... January 23, 2018Business, Finances, Insurance & RegulatoryBy Todd Dennison
Acalabrutinib Receives US FDA Accelerated Approval 2017 remains a banner year for B cell lymphomas and chronic lymphocytic leukemia (CLL) is a B cell lymphoma. The good... October 31, 2017Business, Finances, Insurance & RegulatoryBy Todd Dennison
Genetic Therapy: The 2nd Approval of CAR-T Therapy for Lymphoma While this article is not specific about chronic lymphocytic leukemia, it is still huge news for all of us with... October 31, 2017Business, Finances, Insurance & RegulatoryBy Todd Dennison
Good News for our CLL friends in the UK: Venetoclax is Approved in Chronic Lymphocytic Leukemia Usually the USA leads the way in drug approval and availability (if not affordability), of novel agents, but this time... October 24, 2017Business, Finances, Insurance & RegulatoryBy Todd Dennison
CLL Ireland 2017: Dr. Thornton Discusses the Unmet Needs in Chronic Lymphocytic Leukemia Last April in Dublin for the launch of CLL Ireland, I had the good fortune to interview Dr. Patrick Thornton... October 17, 2017NewsBy Todd Dennison
Ibrutinib Added to PBS Providing Reimbursement for CLL/SLL Patients In Australia October 9, 2017 – Ibrutnib (Imbruvica) has been added to the Pharmaceutical Benefits Scheme, making it available at an average... October 14, 2017Business, Finances, Insurance & RegulatoryBy Todd Dennison
CLL Ireland 2017: Dr. Talha Munir on Combination Therapies in CLL Dr. Talha Munir works with Dr. Peter Hillmen and others at Leeds in the UK on fast moving trials for... September 26, 2017NewsBy Todd Dennison
